Seeking Control for Moderate-to-Severe Asthma: The Underestimated Impact of Comorbidities Along the Lifespan

Target Audience
The primary target audience for this activity are pulmonologists, allergists/immunologists, and specialty advanced practice providers (NPs and PAs). The secondary audience for this activity are primary care physicians, and general practice NPs and PAs.

Program Overview
Severe uncontrolled asthma leads to multiple negative health and socioeconomic effects. Asthma is also associated with comorbid conditions, some driven by shared type 2 inflammatory pathophysiology, including atopic dermatitis, chronic rhinosinusitis with or without nasal polyps (CRSwNP, CRSsNP), eosinophilic esophagitis (EoE), and chronic urticaria. Some of these comorbidities may aggravate and complicate asthma management and contribute to poor treatment response. Poorly controlled asthma in children can have lasting effects on lung development as well.

Join Michael Wechsler, MD and Anju Peters, MD, who will discuss strategies to recognize and better manage moderate‐to‐severe asthma in adults and children. Our panelists will review the latest asthma guidelines, explore the evidence supporting biologic treatments, and reinforce best practices in patient-centered care.

Learning Objectives
After completing this activity, the participant should be better able to:

Summarize the negative effects of comorbidities on asthma disease burden and the ability to achieve asthma control
Explain the negative outcomes on lung development on the failure to achieve optimum asthma control in children
Discuss the role of patient and caregiver preferences in the shared decision‐making process and how to align treatment priorities